Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Glioma × sapanisertib × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Advanced Nonhematologic Malignancies 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Somatostatinoma 1 Sarcoma, Synovial 1 Sarcoma 1 Recurrent Lung Squamous Cell Carcinoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-hematologic Malignancy 1 Neurofibrosarcoma 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hematologic Neoplasms 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Dermatofibrosarcoma 1 Carcinoma, Transitional Cell 1

Interventions

Temozolomide 47 Bevacizumab 41 Radiotherapy 17 Magnetic Resonance Spectroscopy 14 Irinotecan 11 Nivolumab 8 Everolimus 7 Radiation 6 X-Rays 5 Phantoms, Imaging 5 Carboplatin 5 poly ICLC 4 pembrolizumab 4 fluorodopa F 18 4 Specimen Handling 4 Nuclear Medicine Department, Hospital 4 Erlotinib Hydrochloride 4 Carmustine 4 ribociclib 3 palbociclib 3 ivosidenib 3 antineoplaston A10 3 Vorinostat 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 Modafinil 3 Lomustine 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Biopsy 3 veliparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡